QCLS Stock Risk & Deep Value Analysis
Q/C Technologies Inc
Technology • Computer Hardware
DVR Score
out of 10
What You Need to Know About QCLS Stock
We analyzed Q/C Technologies Inc using our deep value framework. Sign in to see our full verdict and DVR Score.
We ran QCLS through our deep value framework — analyzing financial health, distress signals, competitive moat, and risk factors. Our risk assessment: Aggressive. Here's what we found.
QCLS Risk Analysis & Red Flags
What Could Go Wrong
The company faces an acute financial crisis, highlighted by a 'going concern' warning for 2024 and negative operating cash flows. Without urgent and substantial funding, QCLS risks bankruptcy, rendering its OPU pivot irrelevant regardless of market potential.
Risk Matrix
Overall
Aggressive
Financial
High
Market
High
Competitive
High
Execution
High
Regulatory
Low
Red Flags
- ⚠
Explicit 'going concern' warning in 2024 audit (8-K, March 11, 2026)
- ⚠
Persistent net losses and negative operating cash flows (2024 financials)
- ⚠
Frequent strategic pivots (from TNF Pharma to DID, now to OPU) suggest lack of sustained success or focus
- ⚠
No clear path to profitability or positive free cash flow
Upcoming Risk Events
- 📅
Failure to secure urgent and sufficient funding in 2026
- 📅
Negative results or delays in OPU development
- 📅
Intensified competition from established tech giants in photonic computing
When to Reconsider
- 🚪
Failure to announce significant capital raise by Q3 2026
- 🚪
Public statements indicating further delays or significant technical hurdles for OPU
- 🚪
Quarterly cash balance drops below current operating expenses for more than one quarter
Unlock QCLS Risk Analysis & Red Flags
Create a free account to see the full analysis
What Does Q/C Technologies Inc (QCLS) Do?
Market Cap
$15.29M
Sector
Technology
Industry
Computer Hardware
Employees
2
Q/C Technologies, Inc., a clinical-stage pharmaceutical company, focuses on developing and commercializing therapeutic platforms based on various therapeutic targets. The company develops Isomyosamine, a clinical stage small molecule that regulates the immunometabolic system to treat autoimmune disease, including sarcopenia, frailty, adverse effects of drugs used to treat diabetes and obesity, rheumatoid arthritis, and inflammatory bowel disease. It also develops Supera-CBD, a synthetic analog of derivative of cannabidiol (CBD) to treat various conditions, including epilepsy, pain and anxiety/depression. The company has a strategic alliance with DADA2 Foundation for research into the rare inflammatory disease DADA2 (Deficiency of Adenosine Deaminase 2). The company was formerly known as TNF Pharmaceuticals, Inc. and changed its name to Q/C Technologies, Inc. in September 2025. The company was founded in 2014 and is headquartered in New York, New York.
Visit Q/C Technologies Inc WebsiteInvestment Thesis
QCLS is a deeply speculative bet on a long-shot, high-impact technological breakthrough in optical AI computing (OPU). Its 10x potential within 3-5 years is entirely dependent on securing critical funding, successfully developing its proprietary photonic architecture to disrupt the AI inference market, and demonstrating leadership capable of navigating a highly competitive landscape.
Is QCLS Stock Undervalued?
Unlock the full AI analysis for QCLS
Get the complete DVR score, risk analysis, and more
Unlock the full report
Create a free account to see the DVR score, risk flags, and AI analysis.
QCLS Price Targets & Strategy
12-Month Target
$8.00
Bull Case
$15.00
Bear Case
$0.50
Valuation Basis
Based on successful capital raise securing cash runway beyond 12 months and initial market validation of OPU technology attracting a speculative P/B of 2.5x current implied book value per share.
Entry Strategy
This is a highly speculative entry. Consider a very small, risk-tolerant position on significant dips below $3.00 if a concrete funding announcement or OPU prototype milestone is achieved.
Exit Strategy
Take profit at $10.00 if significant OPU progress is validated. Stop loss at $2.00 if no funding announced within 3-6 months or negative OPU developments.
Portfolio Allocation
0.5% - 1% for aggressive, highly speculative portfolios only.
Price Targets & Strategy
Upgrade to Premium for price targets and entry/exit strategies
Does QCLS Have a Competitive Moat?
Sign in to unlockMoat Rating
⚪ None
Moat Trend
Eroding - Constant pivots and financial fragility prevent development of sustainable moats.
Moat Sources
1 Identified
Currently, no durable moat exists. The potential for a moat relies entirely on successfully developing and patenting its OPU technology, which is highly uncertain given the company's financial state and execution track record.
Moat Erosion Risks
- •Failure to secure patents or develop truly proprietary OPU technology
- •Large-scale R&D investments by established tech giants dwarfing QCLS's efforts
- •Inability to commercialize OPU effectively, even if technologically viable
QCLS Competitive Moat Analysis
Sign up to see competitive advantages
QCLS Market Intelligence
Sentiment & Insider Activity
Social Sentiment
Neutral - Highly speculative, with limited public discourse given the recent pivot and dire financials.
Institutional Sentiment
Neutral - No analyst coverage; institutional ownership largely concentrated with PharmaCyte Biotech (74% as of Nov 2025) with no recent updates.
Insider Activity (Form 4)
No specific Form 4 filings reported in last 90 days (January 25 to March 25, 2026). PharmaCyte Biotech, Inc. holds 74.00% of shares as of November 18, 2025 filing (no updates since).
Options Flow
Normal options activity - No unusual options activity reported.
Earnings Intelligence
Next Earnings
No consensus estimates or expected dates available in search results.
Surprise Probability
Low - No estimates available; historical performance indicates losses.
Historical Earnings Pattern
No discernable pattern due to financial instability and constant business pivots; stock price driven by speculative news or funding announcements.
Key Metrics to Watch
Competitive Position
Top Competitor
No direct peer given for OPU, general sector mentions photonic computing as potential disruptor to NVIDIA.
Market Share Trend
Not applicable - Company is pivoting into a new, nascent market where it has no established share.
Valuation vs Peers
Trading at a significant discount on P/B (1.11x vs industry median 4.63x), reflecting its severe financial distress and speculative nature rather than competitive valuation.
Competitive Advantages
- •Potential proprietary silicon photonic computing architecture for AI inference (theoretical)
- •Early mover advantage in a highly specialized niche of AI hardware (if successful)
Market Intelligence
Get sentiment, earnings intel, and peer analysis with Premium
What Could Drive QCLS Stock Higher?
Near-Term (0-6 months)
- •Announcement of successful capital raise (funding critical for survival)
- •First public demonstration or detailed whitepaper of OPU technology (Q3-Q4 2026)
Medium-Term (6-18 months)
- •Strategic partnership for OPU development or market access (H1 2027)
- •Development of early OPU prototype / minimal viable product (H2 2027)
Long-Term (18+ months)
- •Significant adoption of OPU as a viable alternative to electronic AI inference systems
- •Disruption of legacy GPU market through superior photonic computing efficiency
Catalysts & Growth Drivers
Upgrade to Premium to see catalysts
What's the Bull Case for QCLS?
- ✓
Concrete milestones and successful prototype demonstrations for the OPU initiative
- ✓
Significant, non-dilutive funding rounds or strategic partnerships
- ✓
Reversal of negative operating cash flow trend and clear path to profitability
Bull Case Analysis
See what could go right with Premium
Competing with QCLS
See how Q/C Technologies Inc compares to related companies
| Company | Market Cap | DVR Score | P/E | Revenue | Profit Margin | Rev Growth | |
|---|---|---|---|---|---|---|---|
Q/C Technologies Inc QCLS | $15.3M | 3.4 | — | — | 0.0% | 0.0% | |
Apple Inc AAPL | $3.9T | 1.5 | 33.2 | $391.0B | 27.0% | 10.1% | Compare → |
Alphabet Inc GOOGL | $4.2T | 1.0 | 31.5 | $402.8B | 32.8% | 15.1% | Compare → |
Meta Platforms Inc META | — | 5.1 | 15.7 | — | 30.1% | 22.2% | Compare → |
Microsoft Corp MSFT | — | 0.5 | — | — | — | — | Compare → |
NVIDIA Corp NVDA | $4.4T | 5.3 | 38.5 | $215.9B | 55.6% | 65.0% | Compare → |
📊 Explore More Stock Analysis
Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential with our AI-powered analysis.
FAQ
What is the DVR Score for Q/C Technologies Inc (QCLS)?
As of March 25, 2026, Q/C Technologies Inc has a DVR Score of 3.4 out of 10, placing it in the "Risk Trap" category. This score is generated by our AI-powered deep value analysis framework that evaluates growth potential, financial health, competitive moat, and risk factors.
What is the market capitalization of Q/C Technologies Inc?
Q/C Technologies Inc's market capitalization is approximately $15.3M. The company operates in the Technology sector within the Computer Hardware industry.
What ticker symbol does Q/C Technologies Inc use?
QCLS is the ticker symbol for Q/C Technologies Inc. The company trades on the NCM.
What is the risk level for QCLS stock?
Our analysis rates Q/C Technologies Inc's overall risk as Aggressive. This assessment considers execution risk, market risk, financial risk, competitive risk, and regulatory risk. For a full breakdown, see the risk analysis section above.
Is Q/C Technologies Inc's revenue growing?
Q/C Technologies Inc has reported revenue growth of 0.0%. Revenue has been declining, which warrants closer examination.
Is QCLS stock profitable?
Q/C Technologies Inc has a profit margin of 0.0%. The company is currently unprofitable.
How often is the QCLS DVR analysis updated?
Our AI-powered analysis of Q/C Technologies Inc is refreshed regularly to incorporate the latest financial data, market conditions, and news. The most recent update was on March 25, 2026.
Important Disclaimer – Not Financial Advice
Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided on this page for QCLS (Q/C Technologies Inc) should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.
All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research, consider your financial situation, and consult with a qualified financial advisor before making any investment decisions.